Literature DB >> 17993230

Roles of multidrug resistance genes in breast cancer chemoresistance.

M Tien Kuo1.   

Abstract

ATP binding cassette (ABC)-containing drug efflux transporters play important roles in regulating intracellular drug concentrations that determine cell sensitivity to chemotherapeutic agents. Of particular relevance to cancer chemotherapy are the transporters P-glycoprotein (Pgp) encoded by multidrug resistance 1 gene, multidrug resistance protein (MRP), and breast cancer resistance protein (BCRP). More than 80% of currently used antitumor agents can be transported by these three transporters, and overexpression of these transporters renders multidrug resistance to a broad spectrum of antitumor agents. Elevated expression of these transporters is frequently found in breast cancers and correlations with elevated expression of Pgp or MRP1 to chemotherapeutic outcomes have been observed in some cases, suggesting that these transporters may contribute to chemoresistance in breast cancers. However, attempts to modulate the activities of these transporters using reversal agents have met with limited success. Future studies should focus on better understanding of the upregulation mechanisms ofABC transporter genes in breast cancers, and of the pharmacologic mechanisms of transporter-reversal agent interactions. These studies may lead to novel strategies for improving chemotherapeutic efficacies through targeted interventions of these ABC transporters.

Entities:  

Mesh:

Year:  2007        PMID: 17993230     DOI: 10.1007/978-0-387-74039-3_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  30 in total

1.  A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer.

Authors:  Jung Hun Oh; Joseph O Deasy
Journal:  Brief Bioinform       Date:  2015-07-27       Impact factor: 11.622

2.  In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.

Authors:  Sai H S Boddu; Jwala Jwala; Monica R Chowdhury; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

3.  Differential dependency network analysis to identify condition-specific topological changes in biological networks.

Authors:  Bai Zhang; Huai Li; Rebecca B Riggins; Ming Zhan; Jianhua Xuan; Zhen Zhang; Eric P Hoffman; Robert Clarke; Yue Wang
Journal:  Bioinformatics       Date:  2008-12-26       Impact factor: 6.937

4.  Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.

Authors:  Wei-Chien Huang; Yun-Ju Chen; Long-Yuan Li; Ya-Ling Wei; Sheng-Chieh Hsu; Shing-Ling Tsai; Pei-Chun Chiu; Wei-Pang Huang; Ying-Nai Wang; Chung-Hsuan Chen; Wei-Chao Chang; Wen-Chang Chang; Andy Jer-En Chen; Chang-Hai Tsai; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

5.  Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.

Authors:  Upal Roy; Geetika Chakravarty; Kerstin Honer Zu Bentrup; Debasis Mondal
Journal:  Biol Pharm Bull       Date:  2009-12       Impact factor: 2.233

6.  The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel.

Authors:  Qian Liu; Hao Zhang; Lisa Smeester; Fei Zou; Matt Kesic; Ilona Jaspers; Jingbo Pi; Rebecca C Fry
Journal:  BMC Med Genomics       Date:  2010-08-13       Impact factor: 3.063

7.  Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.

Authors:  Lilly Y W Bourguignon; Weiliang Xia; Gabriel Wong
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 8.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

9.  Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.

Authors:  Lilly Y W Bourguignon; Christina C Spevak; Gabriel Wong; Weiliang Xia; Eli Gilad
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

10.  In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance.

Authors:  Zhi Li; Haiping Song; Wenshan He; Yuan Tian; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.